Should I Buy PFE Stock in 2026?

Data-driven analysis and honest assessment for Pfizer Inc

Analysis Updated:
HOLDMixed signals - suitable for existing holders

Current Price: $27.65P/E: 19.9

Decision Score

5.6/10

Hold

Based on 6 fundamental factors

Score Breakdown:

Valuation (20%)7/10

Reasonable P/E of 19.9

Growth (20%)3/10

Declining -0%

Profitability (20%)4/10

Thin margins (0% net)

Financial Health (15%)5/10

Financial health data limited

Cash Flow (15%)10/10

Excellent FCF yield of 11.7%

Insider Activity (10%)5/10

Balanced insider activity

Key Investment Metrics

Current Price

$27.65

P/E Ratio

19.93

Revenue Growth

-0.0%

Profit Margin

0.1%

Market Cap

$154.1B

Dividend Yield

0.06%

How PFE Compares to Competitors

Understanding how PFE stacks up against peers helps inform your investment decision.

How PFE Compares to Peers

Upcoming Events for PFE

+5 Reasons TO Buy PFE

1. High gross margins of 76%

strong

Gross margins above 50% typically indicate strong brand value or intellectual property moats.

2. High free cash flow yield of 11.7%

strong

FCF yield above 5% means substantial cash generation for dividends, buybacks, or reinvestment.

3. Large-cap stability and market leadership

moderate

With market cap over $100B, this company has established leadership and resources to weather cycles.

-5 Reasons NOT to Buy PFE

1. Thin profit margins of 0.1%

high risk

Low margins provide little cushion against cost increases or pricing pressure.

2. High PEG ratio of 13.8

high risk

PEG above 2 suggests expensive relative to growth rate.

3. Revenue declining 0%

medium risk

Shrinking revenue suggests loss of market share or weakening demand. Turnarounds are difficult.

Who Should Buy PFE?

Investment Profile

Risk Level

Medium

Recommended Holding Period

3-5 years

Best For:

    Not Suitable For:

    • Growth Investors

      Limited -0% growth may disappoint

    • Income-Focused Retirees

      Low 0.1% yield

    Consider These Alternatives

    If you're interested in PFE, compare these Health Care peers:

    Pro tip: Compare PFE directly with competitors using our comparison tool to see which stock better fits your criteria.

    Get the Full Picture

    Access AI-powered insights, DCF valuations, insider trading data, and real-time analysis for PFE

    Frequently Asked Questions

    What is PFE stock price today?

    PFE (Pfizer Inc) stock is trading at $27.65 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

    Is PFE stock going up or down today?

    PFE stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

    Should I buy PFE stock now?

    The decision to buy PFE depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

    Is PFE a buy, hold, or sell right now?

    Our AI-powered analysis provides buy/hold/sell recommendations for PFE based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

    Is PFE stock overvalued or undervalued?

    PFE currently trades at a P/E ratio of 19.93 relative to earnings. Our DCF calculator provides intrinsic value estimates to help determine if PFE is fairly priced.

    What is PFE's P/E ratio?

    PFE has a price-to-earnings (P/E) ratio of 19.93, which measures how much investors are willing to pay per dollar of earnings. Compare this to industry peers and historical averages for context.

    What is PFE's market cap?

    PFE (Pfizer Inc) has a market capitalization of $154.08 billion, making it a mid-cap stock.

    What is PFE's price to book ratio?

    PFE trades at a price-to-book (P/B) ratio of 1.66, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.

    Similar Investment Decisions

    Explore investment analyses for stocks similar to Pfizer Inc

    Explore Categories

    Disclaimer

    This analysis is for informational purposes only and should not be considered financial advice. The decision score and recommendations are based on quantitative factors and do not account for all risks, your personal financial situation, or qualitative factors. Always do your own research and consider consulting with a financial advisor before making investment decisions.